Argeris N. Karabelas, Director at REGENXBIO Inc. (RGNX), sold 11,000 shares at $15.05 ($166K) on 2024-07-29, disclosed to the SEC on 2024-07-30.
Scheduled sale ($166k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |
| VRX | BUY | 2016-08-12 | $99K | — | Filing → |